Researchers studied the relationship between high HDL-C levels and mortality in patients with coronary artery disease.
A study was done to assess if patients with familial hypercholesterolemia who take statins have increased risk for dementia.
Researchers sought to examine the effect of statin therapy on recurrent major adverse cardiovascular events.
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
A team of investigators used a novel quantitative assessment to evaluate the effect pelacarsen on directly measured Lp(a)-C.
For patients with stroke of atherothrombotic origin, hypertriglyceridemia is associated with residual vascular risk.
Researchers investigated the efficacy of a new drug containing a naturally derived krill oil mixture for treatment of severe hypertriglyceridemia.
Inclisiran is a chemically synthesized small interfering RNA that targets proprotein convertase subtilisin-kexin type 9 (PCSK9) messenger RNA.
The approval of Repatha was also expanded to include patients 10 years of age and older with HoFH.
Researchers evaluated the association between baseline LDL-C and treatment with ezetimibe plus statins in post-acute coronary syndrome.
Children diagnosed with type 2 diabetes may face certain health challenges that grow worse over time and follow them into adulthood.